Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertoldo

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Aging Clinical and Experimental Research|February 20, 2008
Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panicFrancesco Bertoldo
Reumatismo|November 14, 2008
[Comment on the article "Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review" by Capsoni Franco]Francesco Bertoldo, Gerolamo Bianchi
Nature Clinical Practice. Oncology|November 27, 2007
Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzleFrancesco Bertoldo, Daniele Santini, Vincenzo Lo Cascio
Expert Opinion on Emerging Drugs|April 10, 2010
Emerging drugs for the management of cancer treatment induced bone lossFrancesco Bertoldo, Serena Pancheri, Sonia Zenari, et al.
Nature Reviews. Clinical Oncology|April 1, 2009
Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancerFrancesco Bertoldo, Giuseppe Tonini, Bruno Vincenzi, et al.
European Journal of Endocrinology|September 2, 2004
Bone development during GH and GnRH analog treatmentFranco Antoniazzi, Giorgio Zamboni, Francesco Bertoldo, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 7, 2012
The role of bone microenvironment, vitamin D and calciumDaniele Santini, Francesco Pantano, Bruno Vincenzi, et al.
Breast Cancer Research : BCR|September 7, 2011
Targeting bone metastases starting from the preneoplastic niche: home sweet homeDaniele Santini, Bruno Vincenzi, Francesco Pantano, et al.
European Journal of Internal Medicine|May 9, 2026
Cumulative nocturnal hypoxemia, but not apnea-hypopnea index, is independently associated with vertebral fracture burden in obstructive sleep apneaFrancesco Bertoldo, Giulia Sartori, Matteo Lombini, et al.
Head & Face Medicine|July 10, 2021
A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesisGiuseppina Campisi, Rodolfo Mauceri, Francesco Bertoldo, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Aging Clinical and Experimental Research|February 20, 2008
Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panicFrancesco Bertoldo
Reumatismo|November 14, 2008
[Comment on the article "Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review" by Capsoni Franco]Francesco Bertoldo, Gerolamo Bianchi
Nature Clinical Practice. Oncology|November 27, 2007
Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzleFrancesco Bertoldo, Daniele Santini, Vincenzo Lo Cascio
Expert Opinion on Emerging Drugs|April 10, 2010
Emerging drugs for the management of cancer treatment induced bone lossFrancesco Bertoldo, Serena Pancheri, Sonia Zenari, et al.
Nature Reviews. Clinical Oncology|April 1, 2009
Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancerFrancesco Bertoldo, Giuseppe Tonini, Bruno Vincenzi, et al.
European Journal of Endocrinology|September 2, 2004
Bone development during GH and GnRH analog treatmentFranco Antoniazzi, Giorgio Zamboni, Francesco Bertoldo, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 7, 2012
The role of bone microenvironment, vitamin D and calciumDaniele Santini, Francesco Pantano, Bruno Vincenzi, et al.
Breast Cancer Research : BCR|September 7, 2011
Targeting bone metastases starting from the preneoplastic niche: home sweet homeDaniele Santini, Bruno Vincenzi, Francesco Pantano, et al.
European Journal of Internal Medicine|May 9, 2026
Cumulative nocturnal hypoxemia, but not apnea-hypopnea index, is independently associated with vertebral fracture burden in obstructive sleep apneaFrancesco Bertoldo, Giulia Sartori, Matteo Lombini, et al.
Head & Face Medicine|July 10, 2021
A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesisGiuseppina Campisi, Rodolfo Mauceri, Francesco Bertoldo, et al.
Pageof 8